Eliem Therapeutics Inc.

NASDAQ: ELYM · Real-Time Price · USD
5.11
-0.05 (-0.97%)
At close: Oct 02, 2024, 8:00 PM

Eliem Therapeutics Revenue

Eliem Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2024, Eliem Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
9
Market Cap
342.68M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.